Andrew Schorr catches up with Dr. Bart Barlogie in Barcelona at a conference to ask the question, if emphasis is being pushed to make Myeloma a chronic disease is cure still a priority?
An excellent interview that of course has some of the scientific complexities that make it difficult for the average layperson to understand, but I think it is worth your time and effort to give it a watch.
I think the thing that always strikes me in these sorts of presentations is coming to terms with the fact that multiple myeloma still has a median age decades older than many of us. Or at least it sure seems that way. When you think of it in these terms, it is heartening that so many researchers and pharmas are working on this obscure, orphan disease that mostly strikes the elderly. Those of us who are not elderly or even close understandably can become frustrated, but we should take heart. There could be little to know interest in this disease as is the fate of so many rare and orphan diseases.
Thank you Mr. Schorr for your continued and tireless work to keep us updated with the viewpoints of researchers and specialists treating this disease.
